|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Cash flows from operating activities | |||||
| Net income | |||||
| Less: Net income attributable to noncontrolling interest | |||||
| Net income attributable to Honeywell | |||||
| Net income from discontinued operations | |||||
| Net income from continuing operations | |||||
| Adjustments to reconcile net income from continuing operations to net cash provided by operating activities | |||||
| Depreciation | |||||
| Amortization | |||||
| Loss (gain) on sale of non-strategic businesses and assets | |||||
| Impairment of assets held for sale | |||||
| Repositioning and other (gains) charges | |||||
| Net payments for repositioning and other charges | |||||
| Resideo indemnification and reimbursement agreement termination payment | |||||
| Asbestos liabilities divestiture payment | |||||
| Pension and other postretirement income | |||||
| Pension and other postretirement benefit payments | |||||
| Stock compensation expense | |||||
| Deferred income taxes | |||||
| Other | |||||
| Changes in assets and liabilities, net of the effects of acquisitions and divestitures | |||||
| Accounts receivable | |||||
| Inventories | |||||
| Other current assets | |||||
| Accounts payable | |||||
| Accrued liabilities | |||||
| Income taxes | |||||
| Net cash provided by operating activities from continuing operations | |||||
| Net cash provided by operating activities from discontinued operations | |||||
| Net cash provided by operating activities | |||||
| Cash flows from investing activities | |||||
| Capital expenditures | |||||
| Proceeds from disposals of property, plant and equipment | |||||
| Increase in investments | |||||
| Decrease in investments | |||||
| Receipts from Garrett Motion Inc. | |||||
| (Payments) receipts from settlements of derivative contracts | |||||
| Cash paid for acquisitions, net of cash acquired | |||||
| Proceeds from sales of businesses, net of fees paid | |||||
| Net cash used for investing activities from continuing operations | |||||
| Net cash used for investing activities from discontinued operations | |||||
| Net cash used for investing activities | |||||
| Cash flows from financing activities | |||||
| Proceeds from issuance of commercial paper and other short-term borrowings | |||||
| Payments of commercial paper and other short-term borrowings | |||||
| Proceeds from issuance of common stock | |||||
| Proceeds from issuance of long-term debt | |||||
| Payments of long-term debt | |||||
| Repurchases of common stock | |||||
| Cash dividends paid | |||||
| Pre-separation funding | |||||
| Spin-off cash | |||||
| Other | |||||
| Net cash (used for) provided by financing activities | |||||
| Effect of foreign exchange rate changes on cash and cash equivalents | |||||
| Net increase (decrease) in cash and cash equivalents | |||||
| Cash and cash equivalents at beginning of period | |||||
| Cash and cash equivalents at end of period | |||||
Loading...